COROMINAS MACIAS, HECTOR FGS
hcorominas@santpau.cat
Arroyo Diaz, Juan Antonio FGS
Barcelo Trias, Montserrat FGS
Bernardez Moreno, Julia IR
Casademont Pou, Jordi FGS
Castellvi Barranco, Ivan FGS
Diaz Torne, Cesar FGS
Dutren Tella, Adriana IR
Garcia Alija, Asier FGS
Hernandez de Sosa, Nerea FGS
Laiz Alonso, Ana Maria FGS
Magallares Lopez, Berta Paula FGS
Moya Alvarado, Patricia FGS
Sainz Comas, Luis FGS
Santos Gutierrez, Alvaro FGS
Sihuro Cervantes, Margarita IR
Tandaipan Jaime, Jose Luis FGS
Torres Bonafonte, Olga Herminia FGS
(JIF 2023)
-Balsa A, Díaz Del Campo Fontecha P, Silva L, Valencia J, Nistal V, León F, Hernández MV, Corominas H, Cáliz R, Aguado JM, Candelas G, Ibargoyen N, Martí A, Plana MN, Puñal J, Park HS, Triñanes Y, Villaverde V. Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis. Reumatologia Clinica. 2023; 19(10). DOI:10.1016/j.reumae.2023.07.004. PMID:38008602. IF:1,200 (Q4/8D). Document type: Article.
-Barceló M, Casademont J, Mascaró J, Gich I, Torres OH. Indoor falls and number of previous falls are independent risk factors for long-term mortality after a hip fracture. AGING CLINICAL AND EXPERIMENTAL RESEARCH. 2023; 35(11). DOI:10.1007/s40520-023-02551-3. PMID:37688755. IF:3,400 (Q2/5D). Document type: Article.
-Boleto G, Reiseter S, Hoffmann AM, Mirouse A, Cacoub P, Matucci M, Silvério M, Fonseca JE, Duarte AC, Pestana J, Riccieri V, Lescoat A, Le E, Castellví I, Tandaipan JL, Airó P, Kuwana M, Kavosi H, Avouac J, Allanore Y. The phenotype of mixed connective tissue disease patients having associated interstitial lung disease. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2023; 63:152258. DOI:10.1016/j.semarthrit.2023.152258. PMID:37696231. IF:4,600 (Q1/2D). Document type: Article.
-Casademont J. Physical examination today. MEDICINA CLINICA. 2023; 160(12). DOI:10.1016/j.medcli.2023.02.001. PMID:36907715. IF:2,600 (Q1/3D). Document type: Editorial Material.
-Colalillo A, Hoffmann A-M, Pellicano C, Romaniello A, Gabrielli A, Hachulla E, Smith V, Simeón C-P, Castellví I, Airò P, Truchetet M-E, Siegert E, Distler O, Rosato E, the C. The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort. AUTOIMMUNITY REVIEWS. 2023; 22(4):103290. DOI:10.1016/j.autrev.2023.103290. PMID:36746368. IF:9,200 (Q1/1D). Document type: Review.
-Corominas H, Young D, Cummings JRF, Bouhnik Y, Armuzzi A, Thaci D, Kim J. Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review. CLINICAL DRUG INVESTIGATION. 2023; 43(8). DOI:10.1007/s40261-023-01284-5. PMID:37615857. IF:2,900 (Q2/5D). Document type: Review.
-Díaz C, Pou MA, Rodríguez B, Pujol E. Living with gout. Experiences, impact and challenges of the disease. Qualitative study through focus groups. Reumatologia Clinica. 2023; 19(3). DOI:10.1016/j.reuma.2022.03.009. PMID:36058814. IF:1,200 (Q4/8D). Document type: Article.
-Hernández N, Cardona R, Casademont J. A 37-Year-Old Man with Familial Hereditary Hemorrhagic Telangiectasia and Pulmonary Arteriovenous Malformations Presenting with Seizures and a Diagnosis of Brain Abscesses. AMERICAN JOURNAL OF CASE REPORTS. 2023; 24:e938548. DOI:10.12659/AJCR.938548. PMID:36841939. IF:1,000 (Q3/6D). Document type: Article.
-Jeria S, Gomez A, Park HS, Calvo E, Corominas H, Pou MA, Diaz C. Effectiveness and safety of anakinra in gouty arthritis: A case series and review of the literature. Frontiers in Medicine. 2023; 9:1089993. DOI:10.3389/fmed.2022.1089993. PMID:36714095. IF:3,100 (Q1/2D). Document type: Article.
-Morillon MB, Norup A, Singh JA, Dalbeth N, Taylor WJ, Kennedy MA, Pedersen BM, Grainger R, Tugwell P, Perez F, Diaz C, Edwards NL, Shea B, Ellingsen TJ, Christensen R, Stamp LK, OMERACT Gout Working GRP. Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2023; 60:152191. DOI:10.1016/j.semarthrit.2023.152191. PMID:36963128. IF:4,600 (Q1/2D). Document type: Article.
-Narváez J, Aburto M, Seoane D, Bonilla G, Acosta O, Candelas G, Cano E, Castellví I, González JM, Corominas H, López B, Martín M, Robles A, Mena N, Rodríguez JA, Ortiz AM, Sabater C, Castrejón I, dos R, Garrote S, Maese J, Silva L, Castañeda S, Valenzuela C. Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology. Reumatologia Clinica. 2023; 19(2). DOI:10.1016/j.reuma.2021.12.006. PMID:35753951. IF:1,200 (Q4/8D). Document type: Article.
-Osuna R, Castellvi I, Mulet M, Ortiz MA, Brough DE, Sabzevari H, Semnani RT, Vidal S. Impaired Regulation by IL-35 in Systemic Sclerosis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(13):10567. DOI:10.3390/ijms241310567. PMID:37445745. IF:4,900 (Q1/3D). Document type: Article.
-Oteo JA, Corominas H, Escudero R, Fariñas F, García JC, Goenaga MA, Guillén S, Mascaró JM, Portillo A. Executive summary of the consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Spanish Society of Neurology (SEN), Spanish Society of Immunology (SEI), Spanish Society of Pediatric Infectology (SEIP), Spanish Society of Rheumatology (SER), and Spanish Academy of Dermatology and Venereology (AEDV), on the diagnosis, treatment and prevention of Lyme borreliosis. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2023; 41(1). DOI:10.1016/j.eimc.2022.03.004. PMID:36621247. IF:2,600 (Q3/6D). Document type: Article.
-Pombo M, Seoane D, Diaz F, Cea L, Sanchez F, Sanchez M, Jovani V, Garcia B, Martinez O, Campos C, Manero J, Diaz C, Bohorquez C, Ros I, Perez Y, Castrejon I. Long-term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis. Musculoskeletal Care. 2023; 21(1). DOI:10.1002/msc.1684. PMID:35996810. IF:1,500 (Q3/7D). Document type: Article.
-Popova E, Paniagua P, Álvarez J, Vives M, González A, García Á, Rivas M, Hermenegildo G, Diaz R, Azparren G, Barceló M, Moustafa A-H, Aguilar R, Ordonez J, Alonso P. The Relevance of Implementing the Systematic Screening of Perioperative Myocardial Injury in Noncardiac Surgery Patients. Journal of Clinical Medicine. 2023; 12(16):5371. DOI:10.3390/jcm12165371. PMID:37629413. IF:3,000 (Q1/2D). Document type: Article.
-Pou MA, Martinez D, Estebanez JL, Aivar M, Gayarre R, Conesa A, Hoyo J, Carbonell C, Reyes C, Diaz C. Validation of gout diagnosis in electronic primary care medical records: A population-based study. JOINT BONE SPINE. 2023; 90(6):105628. DOI:10.1016/j.jbspin.2023.105628. PMID:37634875. IF:3,800 (Q1/3D). Document type: Article.
-Queiro R, Seoane D, Laiz A, Agirregoikoa EG, Montilla C, Park HS, Pinto JA, Bethencourt JJ, Ibáñez BJ, Toniolo E, Ramírez J, Marcos AG. Confounders contributing to explain the association between sex and disease impact in patients with recent-onset psoriatic arthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2023; 41(1). DOI:10.55563/clinexprheumatol/077ul6. PMID:35699067. IF:3,400 (Q2/3D). Document type: Article.
-Queiro R, Seoane D, Laiz A, Galindez E, Montilla C, Park HS, Tasende JAP, Baute JJB, Joven B, Toniolo E, Ramírez J, Montero N, Pruenza García C, Serrano A, on behalf of the Proyecto REAPSER Study G. Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis—Multivariable Prediction Model Based on Machine Learning. Journal of Clinical Medicine. 2023; 12(3):931. DOI:10.3390/jcm12030931. PMID:36769579. IF:3,000 (Q1/2D). Document type: Article.
-Sainz L, Riera P, Moya P, Bernal S, Casademont J, Díaz C, Millán AM, Park HS, Lasa A, Corominas H. Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis. Journal of Personalized Medicine. 2023; 13(1):61. DOI:10.3390/jpm13010061. PMID:36675722. IF:3,000 (Q1/2D). Document type: Article.
-Sainz L, Riera P, Moya P, Bernal S, Casademont J, Diaz C, Millan AM, Park HS, Lasa A, Corominas H. Impact of IL6R genetic variants on treatment efficacy and toxicity response to sarilumab in rheumatoid arthritis. ARTHRITIS RESEARCH & THERAPY. 2023; 25(1):226. DOI:10.1186/s13075-023-03209-1. PMID:38001504. IF:4,400 (Q1/3D). Document type: Article.
-Sanmarti R, Corominas H. Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review. Journal of Clinical Medicine. 2023; 12(5):1734. DOI:10.3390/jcm12051734. PMID:36902522. IF:3,000 (Q1/2D). Document type: Review.
-Tandaipan J, Guillén A, Simeón CP, Carreira PE, De la Puente C, Narváez J, Lluch J, Rubio M, Alegre JJ, Bonilla G, Moriano C, Casafont I, García R, Ortiz V, Riera E, Atienza B, Blanco R, Galisteo C, Gonzalez JJ, Pego JM, Pros A, Heredia S, Castellví I. Immunoglobulins in systemic sclerosis management. A large multicenter experience. AUTOIMMUNITY REVIEWS. 2023; 22(11):103441. DOI:10.1016/j.autrev.2023.103441. PMID:37708984. IF:9,200 (Q1/1D). Document type: Article.
-Valero C, Urgelles JF, Sallés M, Joven BE, de Juanes A, Ramírez J, Juanola X, Almodóvar R, Laiz A, Moreno M, Pujol M, Beltrán E, Pinto JA, Crespí L, Sala L, Castañeda S, García R. Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain. Frontiers in Immunology. 2023; 14:1283251. DOI:10.3389/fimmu.2023.1283251. PMID:37936691. IF:5,700 (Q1/3D). Document type: Article.
-Vallez L, Gasó I, Marcos Á, Garrido G, Riera A, Plaza A, Martinez C, Mangues MA, Corominas H. Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib. CLINICAL RHEUMATOLOGY. 2023; DOI:10.1007/s10067-023-06787-2. PMID:37831336. IF:2,900 (Q2/4D). Document type: Article.
(JIF 2022)